UA118576C2 - Фармацевтична композиція, яка містить бринзоламід - Google Patents

Фармацевтична композиція, яка містить бринзоламід

Info

Publication number
UA118576C2
UA118576C2 UAA201608992A UAA201608992A UA118576C2 UA 118576 C2 UA118576 C2 UA 118576C2 UA A201608992 A UAA201608992 A UA A201608992A UA A201608992 A UAA201608992 A UA A201608992A UA 118576 C2 UA118576 C2 UA 118576C2
Authority
UA
Ukraine
Prior art keywords
brinzolamide
pharmaceutical composition
formulation
soluplus
manufacturability
Prior art date
Application number
UAA201608992A
Other languages
English (en)
Inventor
Мандар В. ШАХ
Дипак Бахрі
Original Assignee
Сентис Фарма Прайвет Лімітед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Сентис Фарма Прайвет Лімітед filed Critical Сентис Фарма Прайвет Лімітед
Publication of UA118576C2 publication Critical patent/UA118576C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Inorganic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Розкриті стерильний водний склад інгібітору карбоангідрази, такого як бринзоламід, у комбінації з полімерами, такими як Солюплюс®, і поверхнево-активною речовиною, такою як полісорбат 80, а також способи його одержання. Склад належить до високосолюбілізованої або аморфної форми поганорозчинних лікарських сполук/діючого інгредієнта (діючих інгредієнтів) для поліпшення їх біодоступності і технологічності.
UAA201608992A 2014-01-24 2015-01-23 Фармацевтична композиція, яка містить бринзоламід UA118576C2 (uk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN223DE2014 2014-01-24
PCT/IB2015/050511 WO2015110993A1 (en) 2014-01-24 2015-01-23 Pharmaceutical composition comprising brinzolamide

Publications (1)

Publication Number Publication Date
UA118576C2 true UA118576C2 (uk) 2019-02-11

Family

ID=53680901

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201608992A UA118576C2 (uk) 2014-01-24 2015-01-23 Фармацевтична композиція, яка містить бринзоламід

Country Status (8)

Country Link
US (2) US10632198B2 (uk)
EP (1) EP3096740B1 (uk)
JP (1) JP6487452B2 (uk)
EA (1) EA036820B1 (uk)
ES (1) ES2838756T3 (uk)
PT (1) PT3096740T (uk)
UA (1) UA118576C2 (uk)
WO (1) WO2015110993A1 (uk)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA034839B1 (ru) * 2014-10-20 2020-03-26 Сентисс Фарма Прайвет Лимитед Офтальмологический раствор
CN105796482B (zh) * 2016-04-19 2019-09-03 浙江工业大学 紫杉醇缓释温敏凝胶及其制备方法
US20190209465A1 (en) * 2016-07-01 2019-07-11 Pharmathen S.A. Process for preparing pharmaceutical ophthalmic compositions of brinzolamide
JP7100635B2 (ja) 2016-11-02 2022-07-13 セントレクシオン セラピューティクス コーポレイション 安定な水性カプサイシン注射製剤およびその医学的使用
AU2018302342A1 (en) 2017-07-20 2020-02-06 Centrexion Therapeutics Corporation Methods and compositions for treatment of pain using capsaicin
CA3073195A1 (en) * 2017-08-15 2019-02-21 Nephron Pharmaceuticals Corporation Aqueous nebulization composition
US11298360B2 (en) 2018-04-25 2022-04-12 Shilpa Medicare Limited Ophthalmic compositions of brinzolamide
CN117598989A (zh) * 2018-08-28 2024-02-27 拨云生物医药科技(广州)有限公司 多激酶抑制剂的乳液制剂

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5153192A (en) 1990-04-09 1992-10-06 Alcon Laboratories, Inc. Thiophene sulfonamides useful as carbonic anhydrase inhibitors
US5378703A (en) * 1990-04-09 1995-01-03 Alcon Laboratories, Inc. Sulfonamides useful as carbonic anhydrase inhibitors
WO1994006411A1 (en) * 1992-09-17 1994-03-31 Alcon Laboratories, Inc. Topical carbonic anhydrase inhibitor composition
US6071904A (en) 1996-12-11 2000-06-06 Alcon Laboratories, Inc. Process for manufacturing ophthalmic suspensions
WO1999063968A1 (fr) * 1998-06-10 1999-12-16 Wakamoto Pharmaceutical Co., Ltd. Preparations aqueuses contenant des medicaments faiblement solubles
TWI544927B (zh) * 2008-03-17 2016-08-11 愛爾康研究有限公司 具有低濃度的表面活性劑以促進治療劑之生物可利用性的藥學組成物
JP2010037327A (ja) * 2008-07-07 2010-02-18 Wakamoto Pharmaceut Co Ltd ブリンゾラミド水性組成物
AU2010325632B2 (en) * 2009-12-03 2014-01-30 Lupin Limited Process for preparing pharmaceutical ophthalmic compositions
US8211450B2 (en) * 2010-05-05 2012-07-03 Senju Usa, Inc. Ophthalmic composition
CN103747786A (zh) * 2011-07-20 2014-04-23 阿勒根公司 比马前列素和溴莫尼定的固定剂量组合
WO2013025696A1 (en) * 2011-08-15 2013-02-21 Teva Pharmaceutical Industries Ltd. Ophthalmic formulations and processes for their preparation
AU2012351948A1 (en) * 2011-12-16 2014-07-10 Allergan, Inc. Ophthalmic compositions comprising polyvinyl capralactam - polyvinyl acetate - polyethylene glycol graft copolymer
WO2013175285A1 (en) 2012-05-21 2013-11-28 Aurobindo Pharma Limited Process for preparing ophthalmic suspension of brinzolamde

Also Published As

Publication number Publication date
JP6487452B2 (ja) 2019-03-20
US11826429B2 (en) 2023-11-28
US10632198B2 (en) 2020-04-28
EA201691490A1 (ru) 2016-12-30
EP3096740A1 (en) 2016-11-30
EA036820B1 (ru) 2020-12-23
EP3096740B1 (en) 2020-09-30
WO2015110993A1 (en) 2015-07-30
PT3096740T (pt) 2020-12-24
JP2017503805A (ja) 2017-02-02
WO2015110993A4 (en) 2015-10-15
ES2838756T3 (es) 2021-07-02
US20200197522A1 (en) 2020-06-25
US20160339105A1 (en) 2016-11-24

Similar Documents

Publication Publication Date Title
UA118576C2 (uk) Фармацевтична композиція, яка містить бринзоламід
WO2016131067A3 (en) Pharmaceutical compositions comprising meloxicam
PH12015502539A1 (en) Cenicriviroc compositions and methods of making and using the same
WO2015165413A8 (zh) 一种新型的稳定型抗体药物耦联物及其制备方法和用途
NZ631100A (en) Soft chewable pharmaceutical products
MX2011007817A (es) Formulacion farmaceutica o alimenticia de liberacion controlada y proceso para su preparacion.
MX2016010179A (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
WO2017037594A3 (zh) 用于减少局部脂肪的医药组成物及其用途
EP3513789A3 (en) Prophylactic and therapeutic agents for fgfr3 diseases
EP4233902A3 (en) Treatment of a disease of the gastrointestinal tract with an integrin inhibitor
IN2014MN01470A (uk)
WO2016065096A8 (en) Platinum-catalyzed silicone drug delivery devices and methods of use thereof
MX2019011271A (es) Compuestos y metodos para el tratamiento de enfermedades parasitarias.
PH12015502556A1 (en) Modified release formulation
PH12016502233A1 (en) (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine
JO3587B1 (ar) أشكال جرعات بينداموستين عن طريق الفم
WO2012085284A3 (en) High drug load pharmaceutical formulations comprising dronedarone and its pharmaceutically acceptable salts
WO2016040814A3 (en) Disulfide polymers and methods of use
PH12016502236A1 (en) (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine
WO2012147101A3 (en) Pharmaceutical compositions of raltegravir, methods of preparation and use thereof
BR112017019364A2 (pt) dispersões sólidas
WO2013127539A3 (de) Pharmazeutische formulierung enthaltend flupirtin
EA201500128A1 (ru) Педиатрические жидкие композиции для перорального введения, содержащие непадутант
MY194591A (en) Pharmaceutical combination formulation
TH167851A (th) (s)-เพอร์ลินโดล และเกลือที่ยอมรับได้ทางเภสัชกรรมของมันสำหรับ การใช้ในยารักษาโรค